Institution Directory

Clinical trials at Northwestern Medicine

Sites in Chicago, IL

Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 12:51 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official matching trials

1126

Shown on this page

Current sort

Live official records

Conditions: Lung Transplant Rejection
Interventions: Prospera; Device
Lead sponsor: Natera, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 11
States / cities: California City, California • Chicago, Illinois • Baltimore, Maryland + 7 more

Conditions: Pregnancy Related, Pre-Eclampsia
Interventions: Modified natural cycle, Programmed cycle; Procedure
Lead sponsor: JHSPH Center for Clinical Trials; Other
Eligibility: 18 Years to 41 Years · Female only
Enrollment: 788 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 15
States / cities: San Francisco, California • Sunnyvale, California • Orange, Connecticut + 12 more

Conditions: Revision Hip Arthroplasty
Interventions: revision hip arthroplasty; Device
Lead sponsor: Medacta USA; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 7
States / cities: Chicago, Illinois • Boston, Massachusetts • Lebanon, New Hampshire + 3 more

Conditions: Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v8
Interventions: Capecitabine, Fluorouracil, Leucovorin, Leucovorin Calcium, Oxaliplatin, Patient Observation; Drug · Other
Lead sponsor: NRG Oncology; Other
Eligibility: 18 Years and older
Enrollment: 635 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 932
States / cities: Birmingham, Alabama • Mobile, Alabama • Anchorage, Alaska + 639 more

Conditions: Transplant; Failure, Kidney
Interventions: Not listed
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Fasudil (WP-0512); Drug
Lead sponsor: Woolsey Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 9
States / cities: Phoenix, Arizona • Aurora, Colorado • Denver, Colorado + 6 more

Conditions: Heart Failure With Preserved Ejection Fraction (HFpEF)
Interventions: STM01; Drug
Lead sponsor: Secretome Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 2
States / cities: Chicago, Illinois • Dallas, Texas

Conditions: Grade 2 Glioma, Residual Glioma, Recurrent Glioma
Interventions: Vorasidenib, Matching Placebo; Drug
Lead sponsor: Institut de Recherches Internationales Servier; Other
Eligibility: 12 Years and older
Enrollment: 331 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 40
States / cities: Birmingham, Alabama • Duarte, California • La Jolla, California + 32 more

Conditions: Anaplastic Thyroid Cancer, Relapsed/Refractory Poorly Differentiated Thyroid Cancer
Interventions: AIC100 CAR T Cells; Biological
Lead sponsor: AffyImmune Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 4
States / cities: Duarte, California • Chicago, Illinois • New York, New York + 1 more

Conditions: Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Hereditary Breast/Ovarian Cancer (brca1, brca2), Ovarian Cancer, Sarcoma, Uterine Leiomyomata, Vaginal Cancer, Vulvar Cancer
Interventions: Ca-125, screening questionnaire administration, Surgery; Other · Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 6,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2000 – 2040
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Barrett's Esophagus, Esophageal Cancer
Interventions: Endoscopic eradication therapies (EET), Esophagectomy, Chemotherapy, Radiation; Procedure · Drug · Radiation
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 100 Years
Enrollment: 5,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2027
U.S. locations: 4
States / cities: Los Angeles, California • Tampa, Florida • Chicago, Illinois + 1 more

Conditions: Myeloproliferative Neoplasm
Interventions: Navitoclax, Ruxolitinib, Celecoxib; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 12
States / cities: Duarte, California • Fullerton, California • La Jolla, California + 9 more

About this Northwestern Medicine institution page

What this page lists: ClinicalTrials.gov records that list Northwestern Medicine in Chicago, IL as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status: A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from: Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do: No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.

Clinical trials at Northwestern Medicine

Filter and sort this campus

Live official records

LAMBDA 002 (Lung Registry) Study

Natural Versus Programmed Frozen Embryo Transfer (NatPro)

M-Vizion™ Macroscopic Radiographic Study

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Quality of Life in Pre and Post Renal Transplant in Hispanic and Non-Hispanic Recipients

Rho Kinase Inhibitor in Amyotrophic Lateral Sclerosis (REAL)

Study in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)

Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO)

Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

About this Northwestern Medicine institution page